N-butyl, N-methyl, 11-[3',17' beta-(dihydroxy)-1',3',5'(10')-estratrien-16' alpha-yl]-9(R/S)-bromo undecanamide: synthesis and 17 beta-HSD inhibiting, estrogenic and antiestrogenic activities.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Steroids

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7846736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and antiestrogenic activity of diaryl thioether derivatives.

  1994cited by this paper
• Expression of human 17 beta-hydroxysteroid dehydrogenase in mammalian cells.

  1992cited by this paper
• 11 beta-amidoalkyl estradiols, a new series of pure antiestrogens.

  1992cited by this paper
• Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues.

  1992cited by this paper
• Synthesis and biological activity of 17 alpha-alkynylamide derivatives of estradiol.

  1991cited by this paper
• Synthesis and biological activity of new halo-steroidal antiestrogens.

  1991cited by this paper
• Therapeutic potential of pure antioestrogens in the treatment of breast cancer.

  1990cited by this paper
• Endocrine pharmacology of antiestrogens as antitumor agents.

  1990cited by this paper
• Novel steroidal pure antiestrogens.

  1989cited by this paper
• Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells

  1989cited by this paper
• Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.

  1988cited by this paper
• Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

  1988cited by this paper
• Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography.

  1987cited by this paper
• Human placental estradiol 17 beta-dehydrogenase: sequence of a histidine-bearing peptide in the catalytic region.

  1986cited by this paper
• Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens.

  1982cited by this paper
• New biospecific adsorbents for the purification of estradiol receptor.

  1978cited by this paper
• Synthesis of 16alpha-bromoacetoxyestradiol 3-methyl ether and study of the steroid binding site of human placental estradiol 17beta-dehydrogenase.

  1975cited by this paper

• Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases.

  2011cites this paper
• Chemical synthesis of the 17-propanamide derivatives of stereoisomeric Δ14-17α- and 17β-estradiols: potential 17β-hydroxysteroid dehydrogenase inhibitors.

  2011cites this paper
• Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.

  2011cites this paper
• Chemical Synthesis, 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitory Activity and Assessment of In Vitro and In Vivo Estrogenic Activities of Estradiol Derivatives

  2008cites this paper
• Neighboring group participation. Part 16. Stereoselective synthesis and receptor-binding examination of the four stereoisomers of 16-bromomethyl-3,17-estradiols.

  2006cites this paper
• Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.

  2005cites this paper
• Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

  2005cites this paper
• The selective estrogen enzyme modulators in breast cancer: a review.

  2004cites this paper
• Synthesis of a First Estradiol-Adenosine Hybrid Compound

  2003cites this paper
• Inhibitors of 17 beta-hydroxysteroid dehydrogenases.

  2003cites this paper
• Synthesis and receptor-binding examination of 16-hydroxymethyl-3,17-estradiol stereoisomers.

  2002cites this paper
• Synthesis and receptor-binding examination of 16-hydroxymethyl-3,17-estradiol stereoisomers.

  2002cites this paper
• Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.

  2000cites this paper
• Synthesis of (5-azido-2-nitrobenzoyl)amido, (4-azido-2-nitrophenyl)amino, and (5-azido-2-nitro-3,4, 6-trifluorophenyl)amino derivatives of 17alpha-methylamino-, 17alpha-ethylamino-, and 17alpha-propylamino-5alpha-dihydrotestosterone as reagents of different linker lengths for the photoaffinity label

  2000cites this paper
• Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.

  1999cites this paper
• Crystallization and preliminary crystal structure of the complex of 17β-hydroxysteroid dehydrogenase with a dual-site inhibitor

  1999cites this paper
• Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation.

  1998cites this paper
• Synthesis, Uterotrophic, and Antiuterotrophic Activities of Some Estradiol Derivatives Containing Thiadiazole, Thiazoline, and Thiazolidinone Moieties

  1997cites this paper
• The metabolism of 16-fluoroestradiols in vivo: chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent.

  1997cites this paper
• D-ring allyl derivatives of 17 beta- and 17 alpha-estradiols: chemical synthesis and 13C NMR data.

  1997cites this paper
• Synthesis and evaluation of estradiol derivatives with 16 alpha-(bromoalkylamide), 16 alpha-(bromoalkyl) or 16 alpha-(bromoalkynyl) side chain as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 without estrogenic activity.

  1996cites this paper
• Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD type 1).

  1995cites this paper
• Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase activity in human placental microsomes.

  1995cites this paper
• 13C nuclear magnetic resonance study of 17 alpha-substituted estradiols.

  1995cites this paper